Top Story

New model predicts HCV progression, liver-related events

New model predicts HCV progression, liver-related events
May 22, 2015

A risk prediction model developed by researchers from University of Michigan Health System, helped identify which patients with hepatitis C virus infection have the most urgent need for new anti-viral treatment, according to newly published data in Hepatology.

“Offering immediate treatment to patients identified as high risk for poor health outcomes would allow these patients to benefit from highly effective treatments as other patients continue to be monitored and their risk assessment updated at each clinic visit,” Monica Konerman, MD, MSc, gastroenterology fellow at the University of Michigan Health System, said in a press release.

Meeting News Coverage

Universal stool donor model for FMT improves screening, reduces costs, delays

May 22, 2015
Study data show the need for evidence-based stool screening standards, and the usefulness of the universal donor model for fecal microbiota transplantation therapy for…

Foundation aims to assist HCV patients with therapy costs

May 22, 2015
The HealthWell Foundation announced the launch of a new fund aimed to assist people living with hepatitis C virus infection who are underinsured, according to a news…
Meeting News Coverage

Naldemedine safely improved opioid-induced constipation in patients with chronic noncancer pain

May 22, 2015
WASHINGTON — Patients with opioid-induced constipation and chronic noncancer pain achieved symptom improvement with naldemedine, according to data from a…
In the Journals

Rotavirus vaccination significantly impacts seizure-related hospitalizations

May 22, 2015
Rotavirus vaccination significantly decreased seizure-related hospitalizations during childhood, which appeared to be highest among the youngest group of infants during…
More News Headlines »
CME
HCV VOICE

HCV VOICE II: Optimizing Virological Outcomes with Integrated HCV Education

This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP.

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis, end-stage liver disease, hepatocellular…
More »
Meeting News Coverage Video
VIDEO: Digital manometry comparable to anorectal manometry for diagnosis of dyssynergic defecation

VIDEO: Digital manometry comparable to anorectal manometry for diagnosis of dyssynergic defecation

May 21, 2015
WASHINGTON — William D. Chey, MD, from the University of Michigan Health System discusses an abstract he…
More »
CME
Pediatric Metabolic Liver Disorders: Diagnostic Challenges via Case Choice

Pediatric Metabolic Liver Disorders: Diagnostic Challenges via Case Choice

This activity is supported by an educational grant from Synageva Biopharma.

Genetic abnormalities affecting the synthesis or catabolism of metabolic enzymes can lead to the development of serious…
More »
morganatic-roan